Annals of Colorectal Research

Published by: Kowsar

BRAF Gene Mutation Analysis in Colorectal Cancer in South of Iran

Farshid Javadi 1 , Bita Geramizadeh 2 , * and Mitra Mirzai 3
Authors Information
1 Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Transplant Research Center, Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Department of Pathology, Molecular Laboratory, School of Medicine, Namazi Teaching Hospital, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Annals of Colorectal Research: June 30, 2014, 2 (2); e19917
  • Published Online: June 29, 2014
  • Article Type: Research Article
  • Received: May 1, 2014
  • Accepted: May 5, 2014
  • DOI: 10.17795/acr-19917

To Cite: Javadi F, Geramizadeh B, Mirzai M. BRAF Gene Mutation Analysis in Colorectal Cancer in South of Iran, Ann Colorectal Res. 2014 ; 2(2):e19917. doi: 10.17795/acr-19917.

Abstract
Copyright © 2014, Colorectal Research Center and Health Policy Research Center of Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12): 2893-917[DOI][PubMed]
  • 2. Marisa L, de Reynies A, Duval A, Selves J, Gaub MP, Vescovo L, et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. 2013; 10(5)[DOI][PubMed]
  • 3. Kanthan R, Senger JL, Kanthan SC. Molecular events in primary and metastatic colorectal carcinoma: a review. Patholog Res Int. 2012; 2012: 597497[DOI][PubMed]
  • 4. Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y. Colorectal cancer: genetics of development and metastasis. J Gastroenterol. 2006; 41(3): 185-92[DOI][PubMed]
  • 5. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med. 2009; 361(25): 2449-60[DOI][PubMed]
  • 6. Samowitz WS. Genetic and epigenetic changes in colon cancer. Exp Mol Pathol. 2008; 85(1): 64-7[DOI][PubMed]
  • 7. Vakiani E, Yantiss RK. Pathologic features and biologic importance of colorectal serrated polyps. Adv Anat Pathol. 2009; 16(2): 79-91[DOI][PubMed]
  • 8. Roskoski RJ. RAF protein-serine/threonine kinases: structure and regulation. Biochem Biophys Res Commun. 2010; 399(3): 313-7[DOI][PubMed]
  • 9. Cantwell-Dorris ER, O'Leary JJ, Sheils OM. BRAFV600E: implications for carcinogenesis and molecular therapy. Mol Cancer Ther. 2011; 10(3): 385-94[DOI][PubMed]
  • 10. Li WQ, Kawakami K, Ruszkiewicz A, Bennett G, Moore J, Iacopetta B. BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status. Mol Cancer. 2006; 5: 2[DOI][PubMed]
  • 11. Tie J, Gibbs P, Lipton L, Christie M, Jorissen RN, Burgess AW, et al. Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation. Int J Cancer. 2011; 128(9): 2075-84[DOI][PubMed]
  • 12. Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, Schmitt F, et al. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? BMC Cancer. 2008; 8: 255[DOI][PubMed]
  • 13. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut. 2009; 58(1): 90-6[DOI][PubMed]
  • 14. Yokota T, Ura T, Shibata N, Takahari D, Shitara K, Nomura M, et al. BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer. Br J Cancer. 2011; 104(5): 856-62[DOI][PubMed]
  • 15. Rasuck CG, Leite SM, Komatsuzaki F, Ferreira AC, Oliveira VC, Gomes KB. Association between methylation in mismatch repair genes, V600E BRAF mutation and microsatellite instability in colorectal cancer patients. Mol Biol Rep. 2012; 39(3): 2553-60[DOI][PubMed]
  • 16. Jensen LH, Dysager L, Lindebjerg J, Kolvra S, Byriel L, Cruger DG. Molecular biology from bench-to-bedside - which colorectal cancer patients should be referred for genetic counselling and risk assessment. Eur J Cancer. 2010; 46(10): 1823-8[DOI][PubMed]
  • 17. Muhammad S, Jiang Z, Liu Z, Kaur K, Wang X. The role of EGFR monoclonal antibodies (MoABs) cetuximab/panitumab, and BRAF inhibitors in BRAF mutated colorectal cancer. J Gastrointest Oncol. 2013; 4(1): 72-81[DOI][PubMed]
  • 18. Katsios C, Ziogas DE, Roukos DH. Colorectal cancer: cetuximab, KRAS, BRAF, PIK3CA mutations and beyond. Expert Rev Gastroenterol Hepatol. 2010; 4(5): 525-9[DOI][PubMed]
  • 19. Pourhoseingholi MA, Zali MR. Colorectal cancer screening: Time for action in Iran. World J Gastrointest Oncol. 2012; 4(4): 82-3[DOI][PubMed]
  • 20. Naghibalhossaini F, Hosseini HM, Mokarram P, Zamani M. High frequency of genes' promoter methylation, but lack of BRAF V600E mutation among Iranian colorectal cancer patients. Pathol Oncol Res. 2011; 17(4): 819-25[DOI][PubMed]
  • 21. Brim H, Mokarram P, Naghibalhossaini F, Saberi-Firoozi M, Al-Mandhari M, Al-Mawaly K, et al. Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study. Mol Cancer. 2008; 7: 68[DOI][PubMed]
  • 22. Ghaffarpour M, Mohammadi Pargoo E, Sobhani S, Pirmoradi S, Mostakhdemin Hosseini Z, Kamali F. PIK3CA and BRAF mutational status and association with clinicopathological features in Iranian colonrectal cancer patients. Cancer Res. 2011; 71(8)[DOI]
  • 23. Nagasaka T, Sasamoto H, Notohara K, Cullings HM, Takeda M, Kimura K, et al. Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol. 2004; 22(22): 4584-94[DOI][PubMed]
  • 24. Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, Murtaugh MA, et al. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res. 2005; 65(14): 6063-9[DOI][PubMed]
  • 25. Miranda E, Destro A, Malesci A, Balladore E, Bianchi P, Baryshnikova E, et al. Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br J Cancer. 2006; 95(8): 1101-7[DOI][PubMed]
  • 26. Samowitz WS, Albertsen H, Sweeney C, Herrick J, Caan BJ, Anderson KE, et al. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst. 2006; 98(23): 1731-8[DOI][PubMed]
  • 27. Maestro ML, Vidaurreta M, Sanz-Casla MT, Rafael S, Veganzones S, Martinez A, et al. Role of the BRAF mutations in the microsatellite instability genetic pathway in sporadic colorectal cancer. Ann Surg Oncol. 2007; 14(3): 1229-36[DOI][PubMed]
  • 28. Lee S, Cho NY, Choi M, Yoo EJ, Kim JH, Kang GH. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Pathol Int. 2008; 58(2): 104-13[DOI][PubMed]
  • 29. Bougatef K, Ouerhani S, Moussa A, Kourda N, Coulet F, Colas C, et al. Prevalence of mutations in APC, CTNNB1, and BRAF in Tunisian patients with sporadic colorectal cancer. Cancer Genet Cytogenet. 2008; 187(1): 12-8[DOI][PubMed]
  • 30. Asaka S, Arai Y, Nishimura Y, Yamaguchi K, Ishikubo T, Yatsuoka T, et al. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B. Carcinogenesis. 2009; 30(3): 494-9[DOI][PubMed]
  • 31. Vilkin A, Niv Y, Nagasaka T, Morgenstern S, Levi Z, Fireman Z, et al. Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel. Cancer. 2009; 115(4): 760-9[DOI][PubMed]
  • 32. Li HT, Lu YY, An YX, Wang X, Zhao QC. KRAS, BRAF and PIK3CA mutations in human colorectal cancer: relationship with metastatic colorectal cancer. Oncol Rep. 2011; 25(6): 1691-7[DOI][PubMed]
  • 33. Luevano-Gonzalez A, Guzman AQ, Ancer Rodriguez J, Ortiz Lopez R, Rojas Martinez A, Gonzalez Guerrero JF, et al. Analysis of DNA mismatch repair proteins expression and BRAF V600E mutation in a subset of early- and late-onset colorectal carcinoma patients in Mexico. Arch Med Res. 2011; 42(6): 457-62[DOI][PubMed]
  • 34. Bond CE, Umapathy A, Buttenshaw RL, Wockner L, Leggett BA, Whitehall VL. Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers. PLoS One. 2012; 7(10)[DOI][PubMed]
  • 35. Sylvester BE, Huo D, Khramtsov A, Zhang J, Smalling RV, Olugbile S, et al. Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution. Clin Cancer Res. 2012; 18(2): 350-9[DOI][PubMed]
  • 36. Hsieh LL, Er TK, Chen CC, Hsieh JS, Chang JG, Liu TC. Characteristics and prevalence of KRAS, BRAF, and PIK3CA mutations in colorectal cancer by high-resolution melting analysis in Taiwanese population. Clin Chim Acta. 2012; 413(19-20): 1605-11[DOI][PubMed]
  • 37. Palomba G, Colombino M, Contu A, Massidda B, Baldino G, Pazzola A, et al. Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia. J Transl Med. 2012; 10: 178[DOI][PubMed]
  • 38. Chaiyapan W, Duangpakdee P, Boonpipattanapong T, Kanngern S, Sangkhathat S. Somatic mutations of K-ras and BRAF in Thai colorectal cancer and their prognostic value. Asian Pac J Cancer Prev. 2013; 14(1): 329-32[PubMed]
  • 39. Yip WK, Choo CW, Leong VC, Leong PP, Jabar MF, Seow HF. Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia. APMIS. 2013; 121(10): 954-66[DOI][PubMed]
  • 40. Aissi S, Buisine MP, Zerimech F, Kourda N, Moussa A, Manai M, et al. Somatic molecular changes and histo-pathological features of colorectal cancer in Tunisia. World J Gastroenterol. 2013; 19(32): 5286-94[DOI][PubMed]
  • 41. Hanna MC, Go C, Roden C, Jones RT, Pochanard P, Javed AY, et al. Colorectal cancers from distinct ancestral populations show variations in BRAF mutation frequency. PLoS One. 2013; 8(9)[DOI][PubMed]
  • 42. Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C, et al. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res. 2002; 62(22): 6451-5[PubMed]
  • 43. Ranjbari N, Almasi S, Mohammadi-Asl J, Rahim F. BRAF mutations in Iranian patients with papillary thyroid carcinoma. Asian Pac J Cancer Prev. 2013; 14(4): 2521-3[PubMed]
  • 44. Mohammadi-Asl J, Larijani B, Khorgami Z, Tavangar SM, Haghpanah V, Mehdipour P. Prevalence of BRAF V600E Mutation in Iranian Patients with Papillary Thyroid Carcinoma: A Single-Center Study. J Appl Sci. 2009; 9(19)
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments